Eli Lilly and Co (LLY)

81.89
NYSE : Health Care
Prev Close 81.94
Day Low/High 81.67 / 82.24
52 Wk Low/High 64.18 / 86.72
Avg Volume 3.89M
Exchange NYSE
Shares Outstanding 1.10B
Market Cap 90.41B
EPS 2.60
P/E Ratio 31.76
Div & Yield 2.08 (2.50%)

Latest News

Here's Why You Should Hope for Panic: Cramer's 'Mad Money' Recap (Friday 4/21/17)

Here's Why You Should Hope for Panic: Cramer's 'Mad Money' Recap (Friday 4/21/17)

Jim Cramer looks at how the French elections are smacking the U.S stock markets. Plus, he has the week-ahead game plan for oil and stocks.

Turnarounds are Tenuous Things: Cramer's 'Mad Money' Recap (Wednesday 04/19/17)

Turnarounds are Tenuous Things: Cramer's 'Mad Money' Recap (Wednesday 04/19/17)

IBM's busted turnaround and difficult transition story shaved more than 50 points off the Dow, says Jim Cramer.

Wall Street Ends Its Losing Streak As Corporate Earnings Take Focus

Wall Street Ends Its Losing Streak As Corporate Earnings Take Focus

Stocks close in positive territory Monday ahead of a big week for U.S. corporate earnings.

Closing Bell: Stocks End Higher As Corporate Earnings Take Focus

Closing Bell: Stocks End Higher As Corporate Earnings Take Focus

Stocks remained in positive territory breaking a three-day losing streak ahead of U.S. corporate earnings this week, despite mounting tension between North Korea and the U.S.

Immunology Among Areas to Watch as Johnson & Johnson Gears Up to Report Results

Immunology Among Areas to Watch as Johnson & Johnson Gears Up to Report Results

JNJ's diabetes and oncology franchises will also be key when the New Brunswick, N.J.-based healthcare giant reports first-quarter numbers Tuesday morning.

Stocks That Are Changing Direction

Stocks That Are Changing Direction

These charts are showing bullish or bearish reversals.

Cramer: Have Faith in International Strength

Cramer: Have Faith in International Strength

Because there are other things that will take the wind out of your sails.

Stocks Higher Ahead of Earnings From Netflix, United Airlines

Stocks Higher Ahead of Earnings From Netflix, United Airlines

Stocks rise on Monday ahead of a big week for U.S. corporate earnings, including reports Monday from Netlfix and United Airlines.

Stocks Higher as Wall Street Focuses on Earnings and Mixed Economic Data

Stocks Higher as Wall Street Focuses on Earnings and Mixed Economic Data

Stocks rise on Monday ahead of a big week for U.S. corporate earnings and as the U.S. issues a warning to North Korea.

Gilead, Pfizer, AbbVie Win From Lilly's Loss

Gilead, Pfizer, AbbVie Win From Lilly's Loss

The FDA action was a win for Pfizer because Xeljanz escapes competition for one year or more.

Biotech Movers: OncoMed, Incyte, Omeros

Biotech Movers: OncoMed, Incyte, Omeros

OncoMed Pharmaceuticals, Incyte and Omeros were among the biotech stock movers in premarket trading on Monday.

Eli Lilly Stock Falls Premarket After FDA Rejects Arthritis Drug Due to Safety Concerns

Eli Lilly Stock Falls Premarket After FDA Rejects Arthritis Drug Due to Safety Concerns

The drug was expected to bring in more than $1 billion in sales by 2020.

Stock Futures Turn Higher as Wall Street Watches North Korea, Awaits Earnings

Stock Futures Turn Higher as Wall Street Watches North Korea, Awaits Earnings

Stock futures turn higher on Monday ahead of a big week for U.S. corporate earnings and as the U.S. issues a warning to North Korea.

Wake Up Wall Street

Wake Up Wall Street

UAL's earnings are expected today.

5 Things You Must Know Before the Market Opens Monday

5 Things You Must Know Before the Market Opens Monday

U.S. stock futures are lower Monday following economic data that came in soft and after the U.S. warns North Korea that its patience with the rogue nation is running out.

Takeaways and Observations; The Good, the Bad and the Ugly: Doug Kass' Views

Takeaways and Observations; The Good, the Bad and the Ugly: Doug Kass' Views

Doug Kass shares his thoughts on Apple, Allergan and Western Digital.

Lilly and Incyte Fall After FDA Rejects Potential Blockbuster for Rheumatoid Arthritis

Lilly and Incyte Fall After FDA Rejects Potential Blockbuster for Rheumatoid Arthritis

Gilead, Pfizer, Abbvie stand to gain from Lilly and Incyte Rheumatoid Arthritis Setback.

U.S. FDA Issues Complete Response Letter For Baricitinib

U.S. FDA Issues Complete Response Letter For Baricitinib

Eli Lilly and Company (NYSE:LLY) and Incyte Corporation (NASDAQ:INCY) announced today that the U.

Jim Cramer: If There Is a Giant Selloff, I Like Eli Lilly

Jim Cramer: If There Is a Giant Selloff, I Like Eli Lilly

TheStreet's Action Alerts PLUS Portfolio Manager Jim Cramer said that if there is a giant selloff in the broader markets, he likes shares of Eli Lilly LLY.

Jim Cramer -- Eli Lilly Is the New 'Darling' of Big Pharma

Jim Cramer -- Eli Lilly Is the New 'Darling' of Big Pharma

Eli Lilly has become the new go-to name in the pharmaceutical space, even over Johnson & Johnson, Cramer said.

How Badly Is the Bill O'Reilly Situation Hurting 21st Century Fox?

How Badly Is the Bill O'Reilly Situation Hurting 21st Century Fox?

As advertiser boycotts of 'The O'Reilly Factor' continue to grow, so do analysts' concerns about the network's bottom line. But the impact may be muted for now.

Barclays Sees Positive Catalysts Ahead for Eli Lilly

Barclays Sees Positive Catalysts Ahead for Eli Lilly

Barclays has an 'overweight' rating on Eli Lilly stock.

Cramer: We Have Nothing to Distinguish the Stocks Right Now

Cramer: We Have Nothing to Distinguish the Stocks Right Now

We know that we are in the era when index managers are ascendant.